These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31719292)

  • 21. Anti-thymocyte globulins for post-transplant graft-versus-host disease prophylaxis-A systematic review and meta-analysis.
    Theurich S; Fischmann H; Chakupurakal G; Shimabukuro-Vornhagen A; Chemnitz JM; Holtick U; Rothe A; Scheid C; Hallek M; Skoetz N; von Bergwelt-Baildon M
    Crit Rev Oncol Hematol; 2013 Oct; 88(1):178-86. PubMed ID: 23561334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation.
    Tan PL; Wagner JE; Auerbach AD; Defor TE; Slungaard A; Macmillan ML
    Pediatr Blood Cancer; 2006 May; 46(5):630-6. PubMed ID: 16078221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does anti-thymocyte globulin have a place in busulfan/fludarabine conditioning for matched related donor hematopoietic stem cell transplantation?
    Ji YS; Lee MS; Min CW; Park SK; Kim SH; Yun J; Kim HJ; Kim KH; Kim CK; Lee KT; Won JH; Hong DS
    Korean J Intern Med; 2016 Jul; 31(4):750-61. PubMed ID: 27017944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fludarabine, cyclophosphamide and horse antithymocyte globulin conditioning regimen for allogeneic peripheral blood stem cell transplantation performed in non-HEPA filter rooms for multiply transfused patients with severe aplastic anemia.
    Kumar R; Prem S; Mahapatra M; Seth T; Chowdhary DR; Mishra P; Pillai L; Narendra AM; Mehra NK; Saxena R; Choudhry VP
    Bone Marrow Transplant; 2006 Apr; 37(8):745-9. PubMed ID: 16518427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus-host disease prophylaxis in haploidentical transplant.
    Ruggeri A; Sun Y; Labopin M; Bacigalupo A; Lorentino F; Arcese W; Santarone S; Gülbas Z; Blaise D; Messina G; Ghavamzadeh A; Malard F; Bruno B; Diez-Martin JL; Koc Y; Ciceri F; Mohty M; Nagler A
    Haematologica; 2017 Feb; 102(2):401-410. PubMed ID: 27758821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-dose total body irradiation, fludarabine, and antithymocyte globulin conditioning for nonmyeloablative allogeneic transplantation.
    Grosskreutz C; Ross V; Scigliano E; Fruchtman S; Isola L
    Biol Blood Marrow Transplant; 2003 Jul; 9(7):453-9. PubMed ID: 12869959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Unrelated donor stem cell transplantation in children: low toxicity using a GvHD-prophylaxis regimen with CSA, MTX, metronidazole,iv-immunoglobulin and ATG].
    Graf Finckenstein F; Zabelina T; Dürken M; Dahlke J; Kröger N; Krüger W; Janka-Schaub G; Erttmann R; Zander AR; Kabisch H
    Klin Padiatr; 2002; 214(4):206-11. PubMed ID: 12165903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
    Ayuk F; Diyachenko G; Zabelina T; Panse J; Wolschke C; Eiermann T; Binder T; Fehse B; Erttmann R; Kabisch H; Bacher U; Kröger N; Zander AR
    Exp Hematol; 2008 Aug; 36(8):1047-54. PubMed ID: 18456390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Favorable effects of low-dose anti-thymocyte globulin in a partially-mismatched HLA group in an unrelated allogeneic stem cell transplantation setting.
    Sohn SK; Moon JH
    Ann Transplant; 2015 Jan; 20():7-15. PubMed ID: 25564881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A third course of anti-thymocyte globulin in aplastic anaemia is only beneficial in previous responders.
    Gupta V; Gordon-Smith EC; Cook G; Parker A; Duguid JK; Wilson KM; Yi QL; Marsh JC
    Br J Haematol; 2005 Apr; 129(1):110-7. PubMed ID: 15801963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of severe aplastic anemia: comparison of bone marrow transplantation to immunotherapy.
    Tzeng CH; Chen PM; Chuang MW; Liu JH; Hsieh RK; Liu CJ; Fan S; Chen KY; Yung CH; Wang SY
    Zhonghua Yi Xue Za Zhi (Taipei); 1989 Jan; 43(1):21-8. PubMed ID: 2670137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.
    Zakerinia M; Khojasteh HN; Ramzi M; Haghshenas M
    Transplant Proc; 2005 Dec; 37(10):4477-81. PubMed ID: 16387149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Thymoglobulin by Stem Cell Source (Peripheral Blood Stem Cell or Bone Marrow) After Myeloablative Stem Cell Transplantation From HLA 10/10-Matched Unrelated Donors: A Report From the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
    Ravinet A; Cabrespine A; Socié G; Milpied N; Yakoub Agha I; Nguyen S; Michallet M; Menard AL; Maillard N; Mohty M; Suarez F; Huynh A; Marchand T; Deteix C; Cassuto JP; Maury S; Chevallier P; Reman O; Peffault de Latour R; Bay JO
    Transplantation; 2016 Aug; 100(8):1732-9. PubMed ID: 26528768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of two types of antithymocyte globulin in the treatment of children with aplastic anemia].
    Xie XT; He W; Shi W; Zhou XX; Qiao XH
    Zhonghua Er Ke Za Zhi; 2016 Apr; 54(4):294-8. PubMed ID: 27055431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of low-dose rabbit anti-thymocyte globulin in unrelated hematopoietic stem cell transplantation.
    Kuriyama K; Fuji S; Inamoto Y; Tajima K; Tanaka T; Inoue Y; Ito R; Hayashi Y; Ito A; Kurosawa S; Kim SW; Yamashita T; Fukuda T
    Int J Hematol; 2016 Apr; 103(4):453-60. PubMed ID: 26857285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of severe aplastic anaemia with anti-thymocyte globulin.
    McCann SR; Sullivan F; Reynolds M; Temperley IJ
    Acta Haematol; 1985; 74(3):144-7. PubMed ID: 3938158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of severe acute graft-versus-host disease with anti-thymocyte globulin.
    Remberger M; Aschan J; Barkholt L; Tollemar J; Ringdén O
    Clin Transplant; 2001 Jun; 15(3):147-53. PubMed ID: 11389703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful bone marrow transplantation with rabbit anti-human thymocyte globulin in aplastic anemia. Report of a case previously treated with equine anti-human lymphocyte globulin.
    Yoshida Y; Ichinoe T; Dodo M; Noukawa M; Maeda A; Oguma S; Tajima M; Yamamoto K; Okuma M
    Int J Hematol; 1994 Jul; 60(1):79-83. PubMed ID: 7919240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome of allogeneic haematopoietic stem cell transplantation in aplastic anaemia.
    Ahmed P; Chaudhry QU; Raza S; Mahmood SK; Satti TM; Anwar M; Altaf C; Shahbaz N; Satti HS
    J Coll Physicians Surg Pak; 2012 Sep; 22(9):553-9. PubMed ID: 22980607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The benefit of ATG in immunosuppressive therapy of children with moderate aplastic anemia.
    Jiang S; Wang Y; Shi W; Shao Y; Qiao X; Lin J; Kuang H; Xie X
    Pediatr Hematol Oncol; 2009; 26(5):313-20. PubMed ID: 19579077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.